Corcept Therapeutics (CORT) Prepaid Assets (2010 - 2026)
Corcept Therapeutics (CORT) posted Prepaid Assets of $41.4 million for Q2 2026, up 15.29% sequentially from $35.9 million in Q1 2026, and up 72.08% YoY from $24.0 million in Q2 2025.
Corcept Therapeutics (CORT) Prepaid Assets (2010 - 2026) Analysis & Trends
Corcept Therapeutics has reported Prepaid Assets for 17 years, with the latest figure at $41.4 million in Q2 2026.
- Quarterly Prepaid Assets rose 72.08% year-over-year to $41.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $41.4 million (up 72.08% YoY) and the FY2025 annual result came in at $40.7 million, up 85.82% from the prior year.
- Prepaid Assets rose to $41.4 million in Q2 2026 per CORT's latest filing, from $35.9 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $41.4 million in Q2 2026 and troughed at $10.4 million in Q1 2022.
- A 5-year average of $25.1 million and a median of $22.9 million in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2024: Prepaid Assets soared 128.08% in 2022, then dropped 20.62% in 2024.
- Over 5 years, Prepaid Assets stood at $16.4 million in 2022, then soared by 67.82% to $27.6 million in 2023, then decreased by 20.62% to $21.9 million in 2024, then jumped by 85.82% to $40.7 million in 2025, then rose by 1.76% to $41.4 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $41.4 million, $35.9 million, and $40.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Corcept Therapeutics | 12.37 Bn | 12.07 Bn | 252.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 41.37 Mn |
| Mar 31, 2026 | 35.89 Mn |
| Dec 31, 2025 | 40.66 Mn |
| Sep 30, 2025 | 37.47 Mn |
| Jun 30, 2025 | 24.04 Mn |
| Mar 31, 2025 | 39.55 Mn |
| Dec 31, 2024 | 21.88 Mn |
| Sep 30, 2024 | 18.88 Mn |
| Jun 30, 2024 | 25.50 Mn |
| Mar 31, 2024 | 23.90 Mn |
| Dec 31, 2023 | 27.56 Mn |
| Sep 30, 2023 | 20.16 Mn |
| Jun 30, 2023 | 15.86 Mn |
| Mar 31, 2023 | 15.87 Mn |
| Dec 31, 2022 | 16.42 Mn |
| Sep 30, 2022 | 20.68 Mn |
| Jun 30, 2022 | 15.36 Mn |
| Mar 31, 2022 | 10.44 Mn |
| Dec 31, 2021 | 10.32 Mn |
| Sep 30, 2021 | 9.07 Mn |